miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R

Glioma is a type of common intracranial tumor. In this study, we investigated the molecular mechanism by which miR-378a-3p regulates cisplatin (CDDP) chemosensitivity in glioma cells via insulin-like growth factor 1 receptor (IGF1R). U251/CDDP cells were treated with CDDP and transfected with miR-37...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang Yunjiang, Du Jia
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
Acceso en línea:https://doaj.org/article/627611fb791741e88f2d9c75e70c301f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:627611fb791741e88f2d9c75e70c301f
record_format dspace
spelling oai:doaj.org-article:627611fb791741e88f2d9c75e70c301f2021-12-05T14:10:42ZmiR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R2391-541210.1515/biol-2021-0117https://doaj.org/article/627611fb791741e88f2d9c75e70c301f2021-11-01T00:00:00Zhttps://doi.org/10.1515/biol-2021-0117https://doaj.org/toc/2391-5412Glioma is a type of common intracranial tumor. In this study, we investigated the molecular mechanism by which miR-378a-3p regulates cisplatin (CDDP) chemosensitivity in glioma cells via insulin-like growth factor 1 receptor (IGF1R). U251/CDDP cells were treated with CDDP and transfected with miR-378a-3p mimics, NC mimics, or pcDNA-IGF1R. qRT-PCR was used to measure the differential level of miR-378a-3p. CCK-8 assay was used to test cell proliferation, and flow cytometry was used to analyze apoptosis. The targeting relationship between miR-378a-3p and IGF1R was tested through a dual-luciferase reporter gene assay. In contrast to normal glial cells, the miR-378a-3p level decreased in human glioma U251 cells and had lower expression in U251/CDDP cells. Compared with the CDDP group, miR-378a-3p significantly caused the inhibition of U251/CDDP cell proliferation and enhanced apoptosis in the miR-378a-3p mimics + CDDP group. Another experiment confirmed that IGF1R was a target gene of miR-378a-3p, and overexpression of miR-378a-3p inhibited IGF1R expression. In addition, co-overexpression of miR-378a-3p and IGF1R induced the upregulation of the U251/CDDP cell proliferation and the inhibition of apoptosis in the miR-378a-3p mimics + pcDNA-IGF1R + CDDP group. This study confirmed that miR-378a-3p promoted the sensitivity of glioma cells to CDDP in glioma patients via targeting IGF1R to increase the therapeutic effect during chemotherapy.Wang YunjiangDu JiaDe Gruyterarticlegliomamir-378a-3pinsulin like growth factor 1 receptorcisplatinchemosensitivityBiology (General)QH301-705.5ENOpen Life Sciences, Vol 16, Iss 1, Pp 1175-1181 (2021)
institution DOAJ
collection DOAJ
language EN
topic glioma
mir-378a-3p
insulin like growth factor 1 receptor
cisplatin
chemosensitivity
Biology (General)
QH301-705.5
spellingShingle glioma
mir-378a-3p
insulin like growth factor 1 receptor
cisplatin
chemosensitivity
Biology (General)
QH301-705.5
Wang Yunjiang
Du Jia
miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R
description Glioma is a type of common intracranial tumor. In this study, we investigated the molecular mechanism by which miR-378a-3p regulates cisplatin (CDDP) chemosensitivity in glioma cells via insulin-like growth factor 1 receptor (IGF1R). U251/CDDP cells were treated with CDDP and transfected with miR-378a-3p mimics, NC mimics, or pcDNA-IGF1R. qRT-PCR was used to measure the differential level of miR-378a-3p. CCK-8 assay was used to test cell proliferation, and flow cytometry was used to analyze apoptosis. The targeting relationship between miR-378a-3p and IGF1R was tested through a dual-luciferase reporter gene assay. In contrast to normal glial cells, the miR-378a-3p level decreased in human glioma U251 cells and had lower expression in U251/CDDP cells. Compared with the CDDP group, miR-378a-3p significantly caused the inhibition of U251/CDDP cell proliferation and enhanced apoptosis in the miR-378a-3p mimics + CDDP group. Another experiment confirmed that IGF1R was a target gene of miR-378a-3p, and overexpression of miR-378a-3p inhibited IGF1R expression. In addition, co-overexpression of miR-378a-3p and IGF1R induced the upregulation of the U251/CDDP cell proliferation and the inhibition of apoptosis in the miR-378a-3p mimics + pcDNA-IGF1R + CDDP group. This study confirmed that miR-378a-3p promoted the sensitivity of glioma cells to CDDP in glioma patients via targeting IGF1R to increase the therapeutic effect during chemotherapy.
format article
author Wang Yunjiang
Du Jia
author_facet Wang Yunjiang
Du Jia
author_sort Wang Yunjiang
title miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R
title_short miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R
title_full miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R
title_fullStr miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R
title_full_unstemmed miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R
title_sort mir-378a-3p regulates glioma cell chemosensitivity to cisplatin through igf1r
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/627611fb791741e88f2d9c75e70c301f
work_keys_str_mv AT wangyunjiang mir378a3pregulatesgliomacellchemosensitivitytocisplatinthroughigf1r
AT dujia mir378a3pregulatesgliomacellchemosensitivitytocisplatinthroughigf1r
_version_ 1718371788171247616